| Literature DB >> 29922415 |
Roya Chegene Lorestani1, Alisha Akya1, Azam Elahi1, Yazdan Hamzavi2.
Abstract
BACKGROUND AND OBJECTIVES: Integrons play a major role in the transmission and accumulation of resistance factors in multidrug resistant bacteria. This study was aimed to evaluate the gene cassettes of class I integron and antimicrobial resistance in isolates of Citrobacter with multidrug resistance (MDR).Entities:
Keywords: Citrobacter; Gene cassettes; Integrons; Multidrug-resistant
Year: 2018 PMID: 29922415 PMCID: PMC6004633
Source DB: PubMed Journal: Iran J Microbiol ISSN: 2008-3289
Oligonucleotide primers used
| Int1F | CAGTGGACATAAGCCTGTTC | 160 | |
| Int1R | CCCGAGGCATAGACTGTA | 160 | |
| 5′ -CS | GGCATCCAAGCAGCAAG | variable | |
| 3′ -CS | AAGCAGACTTGACCTGA | variable |
Fig. 1.Antimicrobial susceptibility patterns of 90 Citrobacter isolates.
SXT: Trimethoprim-sulfamethoxazole, CIP: Ciprofloxacin, TN: Tobramycin, GM: Gentamicin, CRO: Ceftriaxone, CTX: Cefotaxime, CAZ: Ceftazidime, ATM: Aztreonam, AP: Ampicilin, S: Streptomycin, CZ: Cefazolin, CPD: Cefpodoxime, ETP: Ertapenem, MEM: Meropenem, PTZ: Tazobactam piperacillin, IMI: Imipeneme.
Characterization of Class1 integrons and gene cassettes in 30 MDR isolates of integron-carrying Citrobacter.
| S1 | Urine | Surgery | AP/CTX/CPD/CAZ/CRO/CIP/CZ/ATM/S/ SXT | + | 750 | |
| S75 | Urine | Surgery | AP/CIP/SXT/S | + | 750 | |
| S2 | Urine | Internal | AP/CTX/CPD/CAZ/CRO/CZ/ATM/S/SXT/TN/GM | + | 1600, 1000 | |
| S6 | Urine | Emergency | AP/CZ/SXT/S | + | 1600, 1000 | |
| S14 | Urine | Internal ICU | AP/CTX/CPD/CAZ/CRO/TN/CIP/CZ/ATM/S/SXT | + | 1600, 1000 | |
| S17 | Urine | Surgery | AP/CAZ/CZ | + | 1600, 1000 | |
| S26 | Urine | Surgery | AP/CTX/CRO/CZ | + | 1600, 1000 | |
| S84 | Respiratory secretions | Infectious | AP/CTX/CPD/CAZ/CRO/PTZ/CZ/SXT/S | + | 1600, 1000 | |
| S86 | Blood | Pediatric | AP/CTX/CZ/S | + | 1600, 1000 | |
| S94 | Stool | Infectious | AP/CTX/CPD/CAZ/ TN/ CZ | + | 1600, 1000 | |
| S97 | Urine | Surgery | AP/TN/CZ | + | 1600, 1000 | |
| S99 | Urine | Pediatric | AP/CZ/S | + | 1600, 1000 | |
| S100 | Urine | Surgery | AP/CAZ/CZ/S | + | 1600, 1000 | |
| S8 | Urine | Surgery | AP/CTX/CPD/CAZ/CRO/CIP/CZ/ATM | + | 700 | Hypothetical protein |
| S10 | Urine | Emergency | AP/CTX/CAZ/CPD/CRO/CZ/SXT/S | + | 1600 | |
| S32 | Stool | Internal | AP/CPD/CZ | + | 1600 | |
| S42 | Respiratory secretions | Surgery | AP/CTX/CAZ/CPD/CRO/TN/GM/IMI/CZ/ S | + | 1600 | |
| S47 | Respiratory secretions | Infectious | AP/CTX/CAZ/CPD/CRO/TN/GM/IMI/CZ/SXT/S | + | 1600 | |
| S60 | Urine | Surgery ICU | CRO/CZ/SXT/S | + | 1600 | |
| S67 | Wound | Surgery | AP/CTX/CRO/CIP/PTZ/IMI/ATM/MEM/SXT/S | + | 1600 | |
| S46 | Respiratory secretions | NICU | AP/CZ/SXT/S | + | 1700, 1600, 1000, 750 | |
| S92 | Stool | Infectious | AP/TN/CZ/SXT/S | + | 1700, 1600, 1000, 750 | |
| S54 | Urine | Surgery | AP/CZ/SXT/SXT/S | + | 1700, 1600, 1000, 600, 500 | |
| S88 | Blood | Infectious | AP/TN/CZ/SXT/S | + | 1700, 1600, 1000, 600, 500 | |
| S91 | Blood | Surgery | AP/CTX/CPD/TN/CZ/SXT/S | + | 1700, 1600, 1000, 600, 500 | |
| S73 | Urine | Infectious | AP/CRO/CZ/SXT/S | + | 1700, 1600 | |
| S85 | Urine | Surgery | AP/CPD/TN/CZ/SXT | + | 1700, 1600 | |
| S79 | Stool | Surgery | AP/CPD/CZSXT/S/SXT | + | 1700, 1600, 1000, 750, 700, 500 | |
| S80 | Urine | Surgery | AP/CPD/CAZ/CIP/CZ/SXT/S | + | 1700, 1600, 1000, 750, 700, 500 | |
| S89 | Blood | Pediatric | AP/CPD/CZ/S | + | 1700, 1600, 1000, 750, 700, 500 |
SXT: Trimethoprim-sulfamethoxazole, CIP: Ciprofloxacin, TN: Tobramycin, GM: Gentamicin, CRO: Ceftriaxone, CTX: Cefotaxime, CAZ: Ceftazidime, ATM: Aztreonam, AP: Ampicilin, S: Streptomycin, CZ: Cefazolin, CPD: Cefpodoxime.
Relatitionship of class I integron and antibiotic resistance among 46 MDR Citrobacter isolates.
| p value | |||||||
|---|---|---|---|---|---|---|---|
| R (%) | S (%) | I (%) | R (%) | S (%) | I (%) | ||
| Aztreonam | 15 (32.6) | 14 (30.4) | 1 (2.2) | 4 (8.7) | 11 (23.9) | 1 (2.2) | 0.257 |
| Imipenem | 2 (4.3) | 24 (52.2) | 4 (8.7) | 0 (0) | 13 (28.3) | 3 (6.5) | 0.53 |
| Cefazolin | 26 (56.2) | 0 (0) | 4 (8.7) | 16 (34.8) | 0 (0) | 0 (0) | 0.126 |
| Ceftazidime | 14 (30.4) | 12 (26) | 4 (8.7) | 8 (17.4) | 8 (17.4) | 0 (0) | 0.302 |
| Cefpodoxime | 15 (32.6) | 10 (21.7) | 5 (10.9) | 6 (13) | 7 (15.2) | 3 (6.5) | 0.708 |
| Tazobactam-Piperacillin | 6 (13) | 17 (36.9) | 7 (15.2) | 0 (0) | 12 (26) | 4 (8.7) | 0.152 |
| Gentamicin | 6 (13) | 24 (52.2) | 0 (0) | 2 (4.3) | 14 (30.4) | 0 (0) | 0.523 |
| Tobramycin | 16 (34.8) | 13 (28.3) | 1 (2.2) | 6 (13) | 9 (19.5) | 1 (2.2) | 0.573 |
| Meropenem | 3 (6.5) | 25 (54.3) | 2 (4.3) | 0 (0) | 14 (30.4) | 2 (4.3) | 0.362 |
| Ciprofloxacin | 15 (32.6) | 13 (28.3) | 2 (4.3) | 0 (0) | 15 (32.6) | 1 (2.2) | 0.002* |
| Ertapenem | 2 (4.3) | 22 (47.8) | 6 (13) | 1 (2.2) | 13 (28.3) | 2 (4.3) | 0.808 |
| Cotrimoxazole | 22 (47.8) | 6 (13) | 2 (4.3) | 6 (13) | 9 (19.5) | 1 (2.2) | 0.041* |
| Cefotaxime | 18 (39.1) | 9 (19.5) | 3 (6.5) | 6 (13) | 9 (19.5) | 1 (2.2) | 0.221 |
| Ampicillin | 29 (63) | 0 (0) | 1 (2.2) | 15 (32.6) | 1 (2.2) | 0 (0) | 0.299 |
| Ceftriaxone | 18 (39.1) | 10 (21.7) | 2 (4.3) | 4 (8.7) | 10 (21.7) | 2 (4.3) | 0.077 |
| Streptomycin | 23 (50) | 7 (15.2) | 0 (0) | 5 (10.9) | 11 (23.9) | 0 (0) | 0.004* |